These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 8436744

  • 1. Clinical and prognostic significance of serum magnesium concentration in patients with severe chronic congestive heart failure: the PROMISE Study.
    Eichhorn EJ, Tandon PK, DiBianco R, Timmis GC, Fenster PE, Shannon J, Packer M.
    J Am Coll Cardiol; 1993 Mar 01; 21(3):634-40. PubMed ID: 8436744
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prognostic importance of the serum magnesium concentration in patients with congestive heart failure.
    Gottlieb SS, Baruch L, Kukin ML, Bernstein JL, Fisher ML, Packer M.
    J Am Coll Cardiol; 1990 Oct 01; 16(4):827-31. PubMed ID: 2212365
    [Abstract] [Full Text] [Related]

  • 4. Effect of phosphodiesterase inhibitors on survival of patients with chronic congestive heart failure.
    Packer M.
    Am J Cardiol; 1989 Jan 03; 63(2):41A-45A. PubMed ID: 2642629
    [Abstract] [Full Text] [Related]

  • 5. Hypomagnesemia in heart failure with ventricular arrhythmias. Beneficial effects of magnesium supplementation.
    Ceremuzyński L, Gebalska J, Wolk R, Makowska E.
    J Intern Med; 2000 Jan 03; 247(1):78-86. PubMed ID: 10672134
    [Abstract] [Full Text] [Related]

  • 6. Serum magnesium aberrations in furosemide (frusemide) treated patients with congestive heart failure: pathophysiological correlates and prognostic evaluation.
    Cohen N, Almoznino-Sarafian D, Zaidenstein R, Alon I, Gorelik O, Shteinshnaider M, Chachashvily S, Averbukh Z, Golik A, Chen-Levy Z, Modai D.
    Heart; 2003 Apr 03; 89(4):411-6. PubMed ID: 12639869
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure.
    Mager G, Klocke RK, Kux A, Höpp HW, Hilger HH.
    Am Heart J; 1991 Jun 03; 121(6 Pt 2):1974-83. PubMed ID: 1852090
    [Abstract] [Full Text] [Related]

  • 13. Improvement of postreceptor events by metoprolol treatment in patients with chronic heart failure.
    Böhm M, Deutsch HJ, Hartmann D, Rosée KL, Stäblein A.
    J Am Coll Cardiol; 1997 Oct 03; 30(4):992-6. PubMed ID: 9316529
    [Abstract] [Full Text] [Related]

  • 14. Multicenter, double-blind study of intravenous milrinone for patients with acute heart failure in Japan. Japan Intravenous Milrinone Investigators.
    Seino Y, Momomura S, Takano T, Hayakawa H, Katoh K.
    Crit Care Med; 1996 Sep 03; 24(9):1490-7. PubMed ID: 8797620
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic achievements of phosphodiesterase inhibitors and the future.
    Jewitt DE.
    Eur Heart J; 1989 Aug 03; 10 Suppl C():53-9. PubMed ID: 2680498
    [Abstract] [Full Text] [Related]

  • 16. Effects of milrinone on complex ventricular arrhythmias in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Ludmer PL, Baim DS, Antman EM, Gauthier DF, Rocco MB, Friedman PL, Colucci WS.
    Am J Cardiol; 1987 Jun 01; 59(15):1351-5. PubMed ID: 3591690
    [Abstract] [Full Text] [Related]

  • 17. The changes of circulating tumor necrosis factor levels in patients with congestive heart failure influenced by therapy.
    Liu L, Zhao SP.
    Int J Cardiol; 1999 Apr 30; 69(1):77-82. PubMed ID: 10362376
    [Abstract] [Full Text] [Related]

  • 18. Effects of intravenous magnesium sulfate on arrhythmias in patients with congestive heart failure.
    Gottlieb SS, Fisher ML, Pressel MD, Patten RD, Weinberg M, Greenberg N.
    Am Heart J; 1993 Jun 30; 125(6):1645-50. PubMed ID: 8498307
    [Abstract] [Full Text] [Related]

  • 19. Diuretic effect of phosphodiesterase inhibitors depends on baseline renal function in patients with congestive heart failure.
    Kanda M, Yasuda S, Goto Y, Sumida H, Baba T, Noguchi T, Nonogi H.
    Am J Cardiol; 1999 Apr 15; 83(8):1274-7, A9. PubMed ID: 10215299
    [Abstract] [Full Text] [Related]

  • 20. Comparing the effects of milrinone and olprinone in patients with congestive heart failure.
    Dobashi S, Watanabe I, Nakanishi R, Hisatake S, Kiuchi S, Kabuki T, Oka T, Fujii T, Ikeda T.
    Heart Vessels; 2020 Jun 15; 35(6):776-785. PubMed ID: 31865433
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.